Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler. 1987

N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
Institute of Respiratory Diseases, University of Catania, Italy.

This trial was performed in a randomized double-blind manner on four different days in 13 asthmatic patients in order to compare the bronchodilator efficacy of two different inhalation devices, Inspirease (IP) and Aerochamber (AC), to the conventional metered dose inhaler (MDI). The results showed that clenbuterol determined a significant FEV1 increase inhaled either via MDI or via IP and AC. IP caused a greater bronchodilatation than AC, 30 min after clenbuterol administration. IP caused a greater mean increase (P less than 0.05) in FEV1 than the MDI at all time intervals; AC provided an improvement in bronchodilator response over directly administered MDI. Such responses are only marginally clinically relevant when patients use MDI correctly. These devices are mainly indicated in patients with poor hand-lung coordination.

UI MeSH Term Description Entries
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002976 Clenbuterol A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. NAB-365,Planipart,NAB 365,NAB365
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
December 1982, The Practitioner,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
April 1994, Annals of allergy,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
January 1995, Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
January 2000, Critical care (London, England),
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
December 1988, Chest,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
December 1992, Respiratory care,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
June 1995, American journal of respiratory and critical care medicine,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
January 1999, The Journal of asthma : official journal of the Association for the Care of Asthma,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
February 1988, The Journal of allergy and clinical immunology,
N Crimi, and F Palermo, and B Cacopardo, and C Vancheri, and R Oliveri, and B Palermo, and A Mistretta
March 1983, The Journal of pediatrics,
Copied contents to your clipboard!